We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2004 by Bispebjerg Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00206921
First Posted: September 21, 2005
Last Update Posted: July 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bispebjerg Hospital
  Purpose
The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.

Condition Intervention
Telangiectasis Erythema Device: Pulsed dye laser Device: Intense pulsed light

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness

Further study details as provided by Bispebjerg Hospital:

Study Start Date: February 2005
Estimated Study Completion Date: August 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • 18 years or older
  • Skin types I, II, III
  • No previous laser or IPL treatment for the condition

Exclusion Criteria:

  • Younger than 18 years old
  • Skin types IV, V, or VI
  • Pregnant or lactating women
  • Previous laser or IPL treatment for the condition
  • Recent exposure to sun or sun-beds
  • Treatment with oral retinoid within 6 months
  • Tendency to produce hypertrophic scars or keloids
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00206921


Contacts
Contact: Merete Hædersdal, MD, PhD, DrMedSci +45 35 31 60 02 mhaedersdal@dadlnet.dk

Locations
Denmark
Bispebjerg Hospital Recruiting
Copenhagen, Copenhagen NV, Denmark, 2400
Contact: Merete Hædersdal, MD, PhD, DrMedSci    +4535316002    mhaedersdal@dadlnet.dk   
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Merete Hædersdal, MD, PhD, DrMedSci Bispebjerg Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00206921     History of Changes
Other Study ID Numbers: KF-01-236/04
First Submitted: September 13, 2005
First Posted: September 21, 2005
Last Update Posted: July 25, 2007
Last Verified: December 2004

Keywords provided by Bispebjerg Hospital:
Telangiectasia
Skin redness

Additional relevant MeSH terms:
Telangiectasis
Erythema
Vascular Diseases
Cardiovascular Diseases
Skin Diseases